摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Nα-(1-carboxy-ethyl)-arginine | 34522-32-2

中文名称
——
中文别名
——
英文名称
Nα-(1-carboxy-ethyl)-arginine
英文别名
Nα-(1-Carboxy-aethyl)-arginin;(+)-octopine;Octopine;Octopin;2-(1-carboxylatoethylazaniumyl)-5-(diaminomethylideneazaniumyl)pentanoate
<i>N</i><sup>α</sup>-(1-carboxy-ethyl)-arginine化学式
CAS
34522-32-2
化学式
C9H18N4O4
mdl
——
分子量
246.266
InChiKey
IMXSCCDUAFEIOE-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    283-284 °C(lit.)
  • 沸点:
    389.26°C (rough estimate)
  • 密度:
    1.2480 (rough estimate)
  • 溶解度:
    甲醇(微溶)、水(微溶、加热、超声处理)
  • 稳定性/保质期:

    在常温常压下稳定。

计算性质

  • 辛醇/水分配系数(LogP):
    -3.7
  • 重原子数:
    17
  • 可旋转键数:
    8
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.67
  • 拓扑面积:
    151
  • 氢给体数:
    5
  • 氢受体数:
    6

安全信息

  • 安全说明:
    S24/25
  • 海关编码:
    2925290090
  • 储存条件:
    密封保存,在-20°C下存放。

SDS

SDS:eb1fafb10532f27749cb5ef8650fc053
查看
Name: (+)-Octopine Material Safety Data Sheet
Synonym: None
CAS: 34522-32-2
Section 1 - Chemical Product MSDS Name:(+)-Octopine Material Safety Data Sheet
Synonym:None

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS# Chemical Name content EINECS#
34522-32-2 (+)-Octopine ca 100 unlisted
Hazard Symbols: None Listed.
Risk Phrases: None Listed.

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
The toxicological properties of this material have not been fully investigated.
Potential Health Effects
Eye:
May cause eye irritation. The toxicological properties of this material have not been fully investigated.
Skin:
May cause skin irritation. The toxicological properties of this material have not been fully investigated.
Ingestion:
May cause irritation of the digestive tract. The toxicological properties of this substance have not been fully investigated.
Inhalation:
May cause respiratory tract irritation. The toxicological properties of this substance have not been fully investigated.
Chronic:
No information found.

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion.
Extinguishing Media:
Use agent most appropriate to extinguish fire. Use water spray, dry chemical, carbon dioxide, or appropriate foam.

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container. Clean up spills immediately, observing precautions in the Protective Equipment section. Avoid generating dusty conditions.
Provide ventilation.

Section 7 - HANDLING and STORAGE
Handling:
Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Use with adequate ventilation. Minimize dust generation and accumulation. Avoid contact with eyes, skin, and clothing. Keep container tightly closed. Avoid ingestion and inhalation.
Storage:
Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 34522-32-2: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Powder
Color: white
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 283.00 - 284.00 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C9H18N4O4
Molecular Weight: 246.27

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials, dust generation, excess heat, strong oxidants.
Incompatibilities with Other Materials:
Oxidizing agents.
Hazardous Decomposition Products:
Carbon monoxide, oxides of nitrogen, irritating and toxic fumes and gases, carbon dioxide.
Hazardous Polymerization: Has not been reported

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 34522-32-2 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
(+)-Octopine - Not listed by ACGIH, IARC, or NTP.

Section 12 - ECOLOGICAL INFORMATION


Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION

IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
S 28A After contact with skin, wash immediately with
plenty of water.
S 37 Wear suitable gloves.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 34522-32-2: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 34522-32-2 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 34522-32-2 is not listed on the TSCA inventory.
It is for research and development use only.


SECTION 16 - ADDITIONAL INFORMATION
N/A

文献信息

  • DEVICE AND METHOD FOR SOLUBILIZING, SEPARATING, REMOVING AND REACTING CARBOXYLIC ACIDS IN OILS, FATS, AQUEOUS OR ORGANIC SOLUTIONS BY MEANS OF MICRO-OR NANOEMULSIFICATION
    申请人:Dietz Ulrich
    公开号:US20130090488A1
    公开(公告)日:2013-04-11
    The present invention is directed to solubilizing compounds, a device and a method for solubilizing and removing carboxylic acids and especially fatty acids from oils, fats, aqueous emulsion, aqueous media and organic solutions. Devices utilizing the inventive method shall be used for separating carboxylic acids from oils, fats, aqueous emulsion, lipophilic media or organic solutions, respectively by preparing an aqueous micro- or nanoemulsion of the carboxylic acids especially the fatty acids and the solubilizing compound which contains at least one amidino and/or gianidino group. Solubilization effects of solubilizing compounds combined with the inventive use of separation methods for carboxylic acids can be used to treat persons in need of removal of fatty acids or analyze carboxylic acids from blood or process other solutions in food, pharmacy, chemistry, bio fuel industry or other industrial processings.
    本发明涉及溶解化合物、用于从油、脂肪、乳液、介质和有机溶液中溶解和去除羧酸,特别是脂肪酸的装置和方法。采用本发明方法的装置将用于通过制备羧酸特别是脂肪酸和含有至少一种基甲酰基和/或基团的溶解化合物的微观或纳米乳液,分离油、脂肪、乳液、亲脂性介质或有机溶液中的羧酸。溶解化合物的溶解效果与本发明所述的羧酸分离方法相结合,可用于治疗需要去除脂肪酸或从血液中分析羧酸或处理食品、药品、化学生物燃料工业或其他工业加工过程中的其他溶液的人员。
  • Device and method for solubilizing, separating, removing and reacting carboxylic acids in aqueous or organic solutions by means of micro- or nanoemulsification
    申请人:Dietz, Ulrich
    公开号:EP2399885A1
    公开(公告)日:2011-12-28
    The invention is related to the emulsification effects achiveable by arginine and arginine analogues on carboxylic acids in aqueous and organic media and the use of these effects to solubilize, separate and remove carboxylic acids as well as increasing physical or chemical interactions and reactions. Furthermore, the invention is directed to the nanoemulsifying properties of arginine and arginine analogues on carboxlic acids and poorly soluble molecules. Solubilization effects of arginine and arginine analogues combined with the inventive use of separation methods for carboxylic acids can be used to treat persons in need of removal of fatty acids or analyze carboxylic acids from blood or process other solutions in food, pharmacy, chemistry or other industrial processings. The inventive effects of arginine and arginine analogues enable the use of methods for nano-filtration of carboxylic acids. Moreover, the use of arginine and arginine anlogues as well as carboxylic acids used to functionalize the interface of micro- and nanofluidic separation media including hydro- or organogels by means of surface functionalization, adsorption or incorporation enables the use of electrophoretic and nanofiltration techniques to be applied on carboxylic acids.
    本发明涉及精酸和精酸类似物在性和有机介质中对羧酸的乳化作用,以及利用这些作用来增溶、分离和去除羧酸以及增加物理或化学相互作用和反应。此外,本发明还涉及精酸和精酸类似物对羧酸和难溶分子的纳米乳化特性。精酸和精酸类似物的增溶作用与羧酸分离方法的创造性使用相结合,可用于治疗需要去除脂肪酸的人,或分析血液中的羧酸,或处理食品、制药、化学或其他工业加工中的其他溶液。精酸和精酸类似物的创造性作用使得纳米过滤羧酸的方法得以使用。此外,使用精酸和精酸类似物以及羧酸,通过表面官能化、吸附或结合的方式,使包括凝胶或有机凝胶在内的微流体和纳米流体分离介质的界面功能化,可将电泳和纳滤技术应用于羧酸
  • Vorrichtung und Verfahren zur Gewinnung von Glycoglycerolipiden und Glycosphingolipiden aus lipoiden Phasen
    申请人:Nanoscience for life GmbH & Co. KG
    公开号:EP2952565A1
    公开(公告)日:2015-12-09
    Die vorliegende Erfindung betrifft eine Vorrichtung und Verfahren zur schonenden und hydrolysefreien Abtrennen von Glycoglycerolipiden als auch von Glycoglycerolipiden und Glycosphingolipiden aus einer lipoiden Phase, welche Glycoglycerolipide und Acylglyceride oder Glycoglycerolipide und Glycosphingolipide und Acylglyceride enthält unter gleichzeitiger effektiver Abreicherung der lipoiden Phasen von besagten Glycoglycerolipiden, Glycoglycerolipiden und Glycosphingolipiden sowie deren Begleitstoffen mittels eines wässrigen Extraktionsverfahrens. Die lipoide Phase wird mit einer wässrigen Phase versetzt, die Anionen eines Salzes enthäl, welches in Wasser bei 20[deg.]C eine Löslichkeit von mindestens 30 g/L besitzt und bei der Dissoziation in Wasser Carbonat, Hydrogencarbonat, Metasilicat, Orthosilicat, Disilicat, Trisilicat, Acetat, Borat oder Tartrat bildet. Eine Vorrichtung zur Durchführung des Verfahrens wird auch beansprucht, wobei die Vorrichtung einen Intensivmischer zur Aufnahme der lipoiden Phase, eine Kavität mit Zuleitung zum Intensivmischer zur Aufnahme einer wässrigen Phase sowie eine Zentrifuge mit Zuleitung zum Intensivmischer umfasst.
    本发明涉及一种从类脂相中温和、无解地分离甘油三酯以及甘油磷脂甘油磷脂的设备和工艺、该工艺包含甘油三酯和酰基甘油酯或甘油三酯和糖磷脂和酰基甘油酯,同时通过萃取工艺有效去除类脂相中的甘油三酯甘油三酯和糖磷脂及其伴随物质。类脂相与含有阴离子盐的相混合,阴离子盐在 20 摄氏度的中溶解度至少为 30 克/升,在中离解时形成碳酸盐、碳酸氢盐、偏硅酸盐、正硅酸盐、二硅酸盐、三硅酸盐、醋酸盐硼酸盐或酒石酸盐。还要求提供一种用于实施该工艺的装置,其中该装置包括一个用于接收类脂相的强化混合器、一个带有通向强化混合器的进料管路用于接收相的空腔和一个带有通向强化混合器的进料管路的离心机。
  • DEVICE FOR SOLUBILIZING, SEPARATING, REMOVING AND REACTING CARBOXYLIC ACIDS IN OILS, FATS, AQUEOUS OR ORGANIC SOLUTIONS BY MEANS OF MICRO- OR NANOEMULSIFICATION
    申请人:Dietz, Ulrich
    公开号:EP3042718A1
    公开(公告)日:2016-07-13
    The present invention is directed to a device for solubilizing and removing carboxylic acids and especially fatty acids from oils, fats, aqueous emulsion, aqueous media and organic solutions. Devices utilizing the herein disclosed method shall be used for separating carboxylic acids from oils, fats, aqueous emulsion, lipophilic media or organic solutions, respectively by preparing an aqueous micro- or nanoemulsion of the carboxylic acids especially the fatty acids and the solubilizing compound which contains at least one amidino and/or gianidino group. Solubilization effects of solubilizing compounds combined with the use of the separation methods for carboxylic acids as discloses herein can be used to treat persons in need of removal of fatty acids or analyze carboxylic acids from blood or process other solutions in food, pharmacy, chemistry, bio fuel industry or other industrial processings.
    本发明涉及一种从油、脂肪、乳液、介质和有机溶液中增溶和去除羧酸,特别是脂肪酸的装置。通过制备羧酸(尤其是脂肪酸)和至少含有一个脒基和/或基的增溶化合物的性微乳液或纳米乳液,利用本文公开的方法制备的设备可分别用于从油、脂肪、性乳液、亲油介质或有机溶液中分离羧酸。增溶化合物的增溶作用与本文公开的羧酸分离方法相结合,可用于治疗需要从血液中去除脂肪酸或分析羧酸的人,或处理食品、制药、化学生物燃料工业或其他工业加工中的其他溶液。
  • Apparatus and method for obtaining glycoglycerolipids and glycosphingolipids from lipid phases
    申请人:Nanoscience for life GmbH & CoKG
    公开号:US10239906B2
    公开(公告)日:2019-03-26
    The present invention relates to an apparatus and method for separating glycoglycerolipids and also glycoglycerolipids and glycosphingolipids from a lipid phase that contains glycoglycerolipids and acyl glycerides or glycoglycerolipids and glycosphingolipids and acyl glycerides, in mild conditions with no hydrolysis and while at the same time effectively depleting the lipid phase of said glycoglycerolipids, glycoglycerolipids and glycosphingolipids and their accompanying substances using an aqueous extraction process.
    本发明涉及一种从含有甘油三酯和酰基甘油酯或甘油三酯和酰基甘油酯的脂相中分离甘油三酯以及甘油三酯和甘磷脂的装置和方法、在不解的温和条件下,同时使用提取工艺有效地去除脂相中的上述甘油三酯甘油三酯和甘磷脂及其伴随物质。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[[[(1R,2R)-2-[[[3,5-双(叔丁基)-2-羟基苯基]亚甲基]氨基]环己基]硫脲基]-N-苄基-N,3,3-三甲基丁酰胺 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,4R)-Boc-4-环己基-吡咯烷-2-羧酸 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-N,3,3-三甲基-N-(苯甲基)丁酰胺 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S)-2-氨基-3,3-二甲基-N-2-吡啶基丁酰胺 (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,5R,6R)-5-(1-乙基丙氧基)-7-氧杂双环[4.1.0]庚-3-烯-3-羧酸乙基酯 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素(1-6) 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸